论文部分内容阅读
新一轮流感季节来临之际,对于儿科用OTC感冒及咳嗽药的安全性的关注度再次升温,虽然美国FDA暂未下达禁令,但是关于这类药物有效性及安全性的讨论并未停止。
Concern over the safety of pediatric OTC flu and cough medicines is on the rise again after the new round of influenza season approaching. Although the FDA has not yet issued a ban, the discussion on the effectiveness and safety of such drugs has not stopped.